4//SEC Filing
Parry Renate 4
Accession 0001140361-25-021790
CIK 0001124105other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:22 PM ET
Size
5.4 KB
Accession
0001140361-25-021790
Insider Transaction Report
Form 4
Parry Renate
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-04+26,000→ 26,000 totalExercise: $8.58Exp: 2035-06-04→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
GYRE THERAPEUTICS, INC.
CIK 0001124105
Entity typeother
Related Parties
1- filerCIK 0001982817
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:22 PM ET
- Size
- 5.4 KB